Randolph M. Johnson
Corporate Officer/Principal chez American Society for Pharmacology & Experimental Therapeutic
Profil
Dr. Randolph M.
Johnson is Executive Vice President-Clinical Development at Endonovo Therapeutics, Inc., Chief Operating Officer at AtheroNova, Inc., CDO & EVP-Preclinical Development at Cortexyme, Inc., a Member at American Society for Pharmacology & Experimental Therapeutic, a Member at Society For Neuroscience and a Member at The Endocrine Society.
Dr. Johnson was previously employed as Chief Technology Officer & VP-Research by KAI Pharmaceuticals, Inc., Senior Vice President-Research by Cellgate, Inc., Senior Vice President-Research by CellGate Technologies LLC, Vice President-Pharmacology & Toxicology by DURECT Corp., a Principal by Genentech, Inc., Director-Research & Development by Syntex Research Centre, and a Professor by University of Virginia.
He received his undergraduate degree from The California State University, a graduate degree from The California State University and a doctorate degree from the University of South Carolina.
Postes actifs de Randolph M. Johnson
| Sociétés | Poste | Début |
|---|---|---|
| American Society for Pharmacology & Experimental Therapeutic | Corporate Officer/Principal | - |
Society For Neuroscience
 Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services The Society for Neuroscience is an organization with over 36,000 members in more than 95 countries. The non-profit company is based in Washington. The organization also engages in science advocacy and public policy, including an annual Capitol Hill Day, and has various public outreach efforts, such as the interactive collection of public-facing resources on BrainFacts.org. It was founded in 1969 and offers year-round programming, including the publication of two scientific journals, professional development resources, and career training through Neuronline. | Corporate Officer/Principal | - |
| The Endocrine Society | Corporate Officer/Principal | - |
Anciens postes connus de Randolph M. Johnson
| Sociétés | Poste | Fin |
|---|---|---|
| ATHERONOVA INC. | Directeur des opérations | - |
| ENDONOVO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| University of Virginia | Corporate Officer/Principal | - |
Syntex Research Centre
 Syntex Research Centre Pharmaceuticals: OtherHealth Technology Syntex Research Centre is a British company that provides pharmaceutical products. Syntex Research Centre was acquired by Quintiles Scotland Ltd on February 01, 1995 for $20.68 million. | Directeur Technique/Scientifique/R&D | - |
Formation de Randolph M. Johnson
| The California State University | Graduate Degree |
| University of South Carolina | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DURECT CORPORATION | Health Technology |
| ENDONOVO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
CellGate Technologies LLC
 CellGate Technologies LLC Computer PeripheralsElectronic Technology Part of StarVox Communications, Inc., CellGate Technologies LLC is a company that manufactures integrated wireless IP modem adapters and provides wireless services. The company is based in Boca Raton, FL. The company was founded by Edgar G. Engleman. CellGate Technologies was acquired by U.S. Wireless Data, Inc. on November 17, 2000 for $2.23 million. | Electronic Technology |
Syntex Research Centre
Syntex Research Centre Pharmaceuticals: OtherHealth Technology Syntex Research Centre is a British company that provides pharmaceutical products. Syntex Research Centre was acquired by Quintiles Scotland Ltd on February 01, 1995 for $20.68 million. | Health Technology |
Cellgate, Inc.
 Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Progen Pharmaceuticals, Inc. develops biopharmaceuticals products. It is engaged in developing improved drug delivery based on their transporter molecules. The company is headquartered in Redwood City, CA. | Health Technology |
| American Society for Pharmacology & Experimental Therapeutic | |
Society For Neuroscience
Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services The Society for Neuroscience is an organization with over 36,000 members in more than 95 countries. The non-profit company is based in Washington. The organization also engages in science advocacy and public policy, including an annual Capitol Hill Day, and has various public outreach efforts, such as the interactive collection of public-facing resources on BrainFacts.org. It was founded in 1969 and offers year-round programming, including the publication of two scientific journals, professional development resources, and career training through Neuronline. | Commercial Services |
| The Endocrine Society | |
AtheroNova, Inc.
 AtheroNova, Inc. Pharmaceuticals: MajorHealth Technology AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA. | Health Technology |